CPIG
NRXP icon

Chicago Partners Investment Group’s NRX Pharmaceuticals NRXP Stock Holding History

Chicago Partners Investment Group’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Buy
34,479
+1,058
+3% +$2.14K ﹤0.01% 1390
2025
Q4 		$72.5K Sell
33,421
-8,573
-20% -$23K ﹤0.01% 1273
2025
Q3 		$126K Buy
+41,994
New +$120K ﹤0.01% 1183

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Chicago Partners Investment Group's NRXP Position: Q1 2026 in Review

Chicago Partners Investment Group increased its NRX Pharmaceuticals (NRXP) stake by 3.2% in Q1 2026, buying an estimated $2.14K and bringing the position to 34,479 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Chicago Partners Investment Group first reported a position in NRXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $126K in Q3 2025. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • Chicago Partners Investment Group held 34,479 shares of NRX Pharmaceuticals worth $102K as of Q1 2026.
  • Chicago Partners Investment Group bought 1,058 NRX Pharmaceuticals shares in Q1 2026, an estimated $2.14K.
  • NRX Pharmaceuticals made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1390 holding.
  • Chicago Partners Investment Group first reported a position in NRX Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Chicago Partners Investment Group's NRX Pharmaceuticals position peaked at $126K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.